Meritxell Nus

Meritxell Nus

Auto-generated profile, based on publicly available information

Meritxell Nus

Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MNMeritxell Nus
Meritxell Nus
ASAndrew P Sage
Andrew P Sage
YLYuning Lu
Yuning Lu
LMLeanne Masters
Leanne Masters
BLBrian Lam
Brian Lam
ZMZiad Mallat
Ziad Mallat

7 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SNStephen A. Newland
Stephen A. Newland
SMSarajo Mohanta
Sarajo Mohanta
MCMarc Clément
Marc Clément
STSoraya Taleb
Soraya Taleb
JWJennifer A. Walker
Jennifer A. Walker
ZMZiad Mallat
Ziad Mallat
Type-2 innate lymphoid cells (ILC2) are a prominent source of type II cytokines and are found constitutively at mucosal surfaces and in visceral adipose tissue. Despite their role in limiting obesity, how ILC2s respond to high fat feeding is poorly understood, and their direct influence on the development of atherosclerosis has not been explored. Here, we show that ILC2 are present in para-aortic adipose tissue and lymph nodes and display an inflammatory-like phenotype atypical of adipose resident ILC2. High fat feeding alters both the number of ILC2 and their type II cytokine production. Selective genetic ablation of ILC2 in Ldlr−/− mice accelerates the development of atherosclerosis, which is prevented by reconstitution with wild type but not Il5−/− or Il13−/− ILC2. We conclude that ILC2 represent a major innate cell source of IL-5 and IL-13 required for mounting atheroprotective immunity, which can be altered by high fat diet.

4 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
MTMinoru Takaoka
Minoru Takaoka
XZXiaohui Zhao
Xiaohui Zhao
HLHwee Ying Lim
Hwee Ying Lim
CMCostan G. Magnussen
Costan G. Magnussen
OAOwen Ang
Owen Ang
ZMZiad Mallat
Ziad Mallat
Hyperlipidaemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Risk of cardiovascular events depends on cumulative lifetime exposure to low-density lipoprotein cholesterol (LDL-C) and, independently, on the time course of exposure to LDL-C, with early exposure being associated with a higher risk1. Furthermore, LDL-C fluctuations are associated with ASCVD outcomes2–4. However, the precise mechanisms behind this increased ASCVD risk are not understood. Here we find that early intermittent feeding of mice on a high-cholesterol Western-type diet (WD) accelerates atherosclerosis compared with late continuous exposure to the WD, despite similar cumulative circulating LDL-C levels. We find that early intermittent hyperlipidaemia alters the number and homeostatic phenotype of resident-like arterial macrophages. Macrophage genes with altered expression are enriched for genes linked to human ASCVD in genome-wide association studies. We show that LYVE1+ resident macrophages are atheroprotective, and identify biological pathways related to actin filament organization, of which alteration accelerates atherosclerosis. Using the Young Finns Study, we show that exposure to cholesterol early in life is significantly associated with the incidence and size of carotid atherosclerotic plaques in mid-adulthood. In summary, our results identify early intermittent exposure to cholesterol as a strong determinant of accelerated atherosclerosis, highlighting the importance of optimal control of hyperlipidaemia early in life, and providing insights into the underlying biological mechanisms. This knowledge will be essential to designing effective therapeutic strategies to combat ASCVD.

1 July 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MNMeritxell Nus
Meritxell Nus
DMDonal MacGrogan
Donal MacGrogan
BMBeatriz Martínez-Poveda
Beatriz Martínez-Poveda
YBYolanda Benito
Yolanda Benito
JCJesús C. Casanova
Jesús C. Casanova
José Luis De La PompaJosé Luis De La Pompa
José Luis De La Pompa
Objective—: Calcific aortic valve disease is similar to atherosclerosis in that both diseases result from chronic inflammation and endothelial dysfunction. Heterozygous NOTCH1 mutations have been associated to calcific aortic disease and a bicuspid aortic valve. We investigated whether mice with genetic inactivation of the Notch signaling pathway are prone to develop valve disease when exposed to a predisposing diet. Methods and Results—: Using Doppler echocardiography, histology, immunohistochemistry, quantitative gene expression analysis, and cell culture assays, we examined the effect of a hypercholesterolemic diet supplemented with vitamin D on mice heterozygous for null mutations in the Notch1 receptor or the effector transcription factor gene RBPJk . After 16 weeks on the hyperlipidemic diet, calcific aortic disease was detected in heterozygous RBPJk mice. Analysis of valve leaflets revealed macrophage infiltration, enhanced collagen deposition, proosteogenic protein expression, and calcification. Heterozygous null Notch1 mice displayed milder histopathologic changes and did not develop any significant hemodynamic disturbance. Valvular disease correlated with reduced expression of the Notch target gene Hey1 in valves of RBPJk heterozygous mice fed the hyperlipidemic diet. Consistent with the in vivo data, Notch signaling inhibition in porcine valve interstitial cells led to downregulation of HEY1 transcription, activation of osteogenic markers, and increased calcified nodule formation. Conclusion—: We show that Notch signaling disruption via RBPJk heterozygous inactivation results in aortic valve disease. Notch1 heterozygous mice do not show functional impairment, suggesting that additional Notch receptors may be involved in aortic valve homeostasis and disease. Our data establish a genetic mouse model of calcific aortic valve disease and may help to identify a patient population with reduced valvular NOTCH signaling at risk for developing this disease.

1 January 2010
Verified
Book Chapter
Closed access
DMDonal MacGrogan
Donal MacGrogan
MNMeritxell Nus
Meritxell Nus
José Luis De La PompaJosé Luis De La Pompa
José Luis De La Pompa

14 April 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
DSDavid Sanchez-Infantes
David Sanchez-Infantes
MNMeritxell Nus
Meritxell Nus
MNMiquel Navas-Madroñal
Miquel Navas-Madroñal
JFJoan Fite
Joan Fite
BPBelen Perez
Belen Perez
Maria GalanMaria Galan
Maria Galan
Abdominal aortic aneurysm (AAA) is increasing due to aging of the population and is a major cause of death among the elderly. Ultrasound screening programs are useful in early diagnosis, but aneurysm size is not always a good predictor of rupture. Our aim was to analyze the value of circulating molecules related to oxidative stress and inflammation as new biomarkers to assist the management of AAA. The markers were quantified by ELISA, and their expression in the aneurysmal wall was studied by real-time PCR and by immunostaining. Correlation analysis of the studied markers with aneurysm diameter and peak wall stress (PWS), obtained by finite element analysis, and multivariate regression analysis to assess potential confounding factors were performed. Our study shows an extensive inflammatory infiltration in the aneurysmal wall, mainly composed by T-cells, macrophages and B-cells and altered levels of reactive oxygen species (ROS), IgM, IgG, CD38, GDF15, S100A4 and CD36 in plasma and in the aneurysmal tissue of AAA patients compared with controls. Circulating levels of IgG, CD38 and GDF15 positively correlated with abdominal aortic diameter, and CD38 was correlated with PWS. Our data show that altered levels of IgG, CD38 and GDF15 have potential diagnostic value in the assessment of AAA.